chrisvoncsefalvay/vaers-outcomes huggingface dataset:
she got her first vaccine dose and "1 week later I caught covid".; This is a spontaneous report from a contactable consumer reported for herself. A female patient of unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, lot number & Expiry date not reported) via an unspecified route of administration on Mar2021 as dose 1, single for COVID-19 immunization. Patient medical history and concomitant medications were not reported. Patient is asking for guidance on getting her second vaccine dose after having covid. Reported that back in March she got her first vaccine dose and "1 week later I caught covid". Caller reports that she was treated in the hospital with Remdesivir. Upon follow up (22Jun2021) patient stated in march she had COVID and then she was treated for which rest of year in hospital and was told wait to 90 days to get the 2nd shot. This past Sunday the 90 days were up and when she went to schedule the second shot and she was told "I have to start the series over". Caller reports that she spoke with her doctor who told her he had not heard of that and that he understood that you wait 90 days and then get the second shot. Patient enquired indeed do I need to now take two more dose of the vaccine even though I have one over 90 days ago. The Outcome of event was unknown.   Follow-up(22Jun2021)This is a spontaneous report from a contactable consumer. This Female consumer (patient) reported for herself that: new information was obtained regarding treatment of Covid-19  Follow-up attempts are needed; information about lot/batch number can be obtained
Information has been received from a health care professional via GlaxoSmithKline (MFR # A0922928A) concerning a 10 weeks old male patient who on 09-FEB-2011, at around 12:00 received the first 0.5 ml dose of PEDIARIX (Lot # AC21B277AA) in the left leg. On the same date, the patient was vaccinated with the first dose of PEDVAXHIB (Lot # 666811/1688Z), PREVNAR (Lot # E12400) and ROTATEQ (Lot # 669070/1268Z). After vaccination, the patient experienced cyanosis, fever, pallor and vomiting and had to be taken to the hospital. The patient was taken to the emergency room. The health care professional considered the events were life threatening and clinically significant (or requiring intervention). At the time of reporting the events were resolved. The healthcare professional considered that the events were probably related to vaccination with PEDIARIX, PEDVAXHIB, PREVNAR and ROTATEQ. A lot check has been initiated. Additional information is not expected.
trouble holding urine/  the patient went to get out bed to use the washroom. Urine came out, and she has never had that problem before. It did it again at 11:30 am; chills; She woke up and was just so cold; head was hurting; feeling dizzy; feeling bad/ felt really bad; lethargic; tired; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP).  A 75 year-old female patient received bnt162b2 (BNT162B2), administered in arm left, administration date 24Mar2021 11:44 (Lot number: ER2613) at the age of 75 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "high cholesterol" (ongoing); "PVC (Premature ventricular contractions)" (ongoing). Concomitant medication(s) included: ATORVASTATIN taken for blood cholesterol increased, start date: 2011 (ongoing); METOPROLOL taken for ventricular extrasystoles (ongoing). Vaccination history included: Shingles shot (a couple of years ago /it was the second dose of that vaccine.), for immunisation, reaction(s): "made her a little fever-ish". The following information was reported: URINARY INCONTINENCE (non-serious) with onset 25Mar2021 02:00, outcome "recovered" (25Mar2021), described as "trouble holding urine/  the patient went to get out bed to use the washroom. Urine came out, and she has never had that problem before. It did it again at 11:30 am"; CHILLS (non-serious) with onset 25Mar2021 02:00, outcome "recovered" (25Mar2021), described as "chills"; FEELING COLD (non-serious) with onset 25Mar2021 02:00, outcome "recovered" (25Mar2021), described as "She woke up and was just so cold"; HEADACHE (non-serious) with onset 25Mar2021 02:00, outcome "recovering", described as "head was hurting"; DIZZINESS (non-serious) with onset 25Mar2021 02:00, outcome "recovering", described as "feeling dizzy"; FEELING ABNORMAL (non-serious) with onset 25Mar2021 02:00, outcome "recovering", described as "feeling bad/ felt really bad"; LETHARGY (non-serious) with onset 25Mar2021 02:00, outcome "recovering", described as "lethargic"; FATIGUE (non-serious) with onset 25Mar2021 02:00, outcome "recovering", described as "tired". Therapeutic measures were not taken as a result of urinary incontinence, chills, feeling cold, headache, dizziness, feeling abnormal, lethargy, fatigue.  Additional Information: The patient started taking atorvastatin around 10 years ago and has been taking metoprolol for 3 or 4 years. The patient has no history of previous immunizations with Pfizer product and has no additional vaccines administered on the same day. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Regarding patient's trouble holding urine, it was reported that the patient has not had this problem since 11:30 am. Patient's chills has gone away pretty much as well. Events did not require visit to Emergency Room nor to Physician Office but the patient stated she was thinking about it and she did not know if she should or not. The patient was reported to be feeling a little bit better.  No follow-up attempts are possible. No further information is expected.
Migraine 12:00 pm 2/17/21 800 mg ibuprofen 11:50 pm 2/17/21 chills, fever, muscle aches 20 ml mucinex severe  0500 2/18/21 chills, fatigue, muscle aches 20 ml mucinex Chills continued until around 1700 2/18/21
I was exposed to COVID on 5/9/2022. I tested on 5/10/2022 which was negative. I started getting symptoms of allergy symptoms scratchy throat, cough, and stuffy nose. Then on 05/13/2022, I went to the urgent care due to my symptoms getting worse and I had a positive COVID-19 test. My symptoms lasted for 2 days. I did have a fever and the fever is still there.
extreme soreness at the injection site, in his left arm, were PNEUMOVAX 23 was given; the patient may have the flu; the patient is not feeling well; fever from 101 that increased to 103; This spontaneous report was received from a pharmacist and refers to a 48 years old male patient with a history of cardiac issue (specific diagnosis was unknown by the reporter). The reporter learned about the event' from the patient's wife. No information on the patient's drug reactions or allergies was provided.  On 29-OCT-2020, the patient was vaccinated with a single dose of pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) lot # T021485, expiration date: 13-MAR-2022, 0.5 milliliter, injection in the left arm and concomitantly with an influenza virus vaccine (manufacturer unknown) (reported as "FLU vaccine").  On 30-OCT-2020, the patient experienced a fever from 101 that increased to 103 (units not provided) and his wife drove the patient to the emergency room. The patient also experienced extreme soreness at the injection site, in his left arm, were pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) was given and was hospitalized on the same day due to this event. The patient's wife also provided that he was not feeling well and she thought the patient might have the flu. It was unknown whether any treatment for the events was given.  The outcome of the events was unknown and the relatedness between the events and pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) was not reported. combinationproductreport: Yes; brandname: PNEUMOVAX23 SYRINGE (DEVICE); commondevicename: Pneumococcal Vaccine, Polyvalent (23-valent); productcode: FMF; devicetype: SYRINGE, PISTON (FMF); manufacturername: Merck Sharp & Dohme Corp. ; devicelotnumber: T021485; expirationdate: 15-MAR-2022; deviceage and unit: 0 ; malfunction: Unknown; deviceusage: Initial; evaluatedbymfr: Not returned to manufacturer; reasonfornoneval: 81 Other; labeledsingleusedevice: No; mdcpreportability: No; mdcpreprationale: Case information does not suggest a causal association with the device or device constituent
Red bumps on arms; Rash all over the body; Itching; This spontaneous case was reported by a consumer and describes the occurrence of LIMB DISCOMFORT (Red bumps on arms), PRURITUS (Itching) and RASH (Rash all over the body) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 041l20A and 031Lz0A) for COVID-19 vaccination.     Concurrent medical conditions included Allergy (Contrast dye allergy).   On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 12-Mar-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced PRURITUS (Itching). On 13-Mar-2021, the patient experienced LIMB DISCOMFORT (Red bumps on arms) and RASH (Rash all over the body). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at an unspecified dose and frequency and HYDROCORTISONE at an unspecified dose and frequency. At the time of the report, LIMB DISCOMFORT (Red bumps on arms), PRURITUS (Itching) and RASH (Rash all over the body) outcome was unknown.            Concomitant medications were not reported.  Treatment details included prescription Hydrocortisone -expired.
Patient received  Pfizer vaccine after initially receiving first dose of  Moderna on March 27,2021 at different location
A rash 5" x 7" on my back, rash on neck; spots on various parts of the body; This is a spontaneous report from a contactable consumer (patient) reported for herself. A 68-year-old non-pregnant female patient (patient was not pregnant at the time of vaccination) received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Lot number: ENS318, Expiry date: unknown), via an unspecified route of administration on 28Jan2021 at 08:30 am (age at the time of vaccination was 68-years-old) on left arm at single dose for covid-19 immunisation. Medical history included hypothryoidism, high blood pressure, C-Diff. The patient did not have allergies to medications, food, or other products. Concomitant medication patient received within 2 weeks of vaccination included levothyroxine sodium (SYNTHROID), lisinopril, desvenlafaxine, solifenacin. The patient A rash 5" x 7" on my back, rash on neck, and spots on various parts of the body on 29Jan2021 at 07:00 am. The adverse event result in Emergency room/department or urgent care. The event was considered as non-serious. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. The patient received Decadron IM 10 mg shot & Medrol 4 mg tab as treatment for the events. The outcome of the events was not recovered.
Allergic reaction in the form of erythema multiforme rash at time most likely related to IPV injection
2 hours after IZ client developed severe dizziness, intermittent chest pain, fever, joint and muscle pain. Advised to go to ER. Pt called next day, did not go to ER but will see private MD today.
This week I tested positive for Covid/symptoms are mild; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (This week I tested positive for Covid/symptoms are mild) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   In January 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In February 2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. In November 2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced COVID-19 (This week I tested positive for Covid/symptoms are mild). At the time of the report, COVID-19 (This week I tested positive for Covid/symptoms are mild) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In December 2021, SARS-CoV-2 test: positive (Positive) Patient tested positive for Covid and so far the symptoms are mild..         Concomitant medication information was not provided by the reporter.                             Treatment information was not provided by the reporter.  The patient had reasonably good health with no major underlying conditions.  I received the Moderna Covid vaccines in January and February, 2021 and the booster shot at the beginning of November. I'm a 71 year old woman in reasonably good health with no major underlying conditions. This week I tested positive for Covid and so far the symptoms are mild.  Company comment: This case concerns a 71-year-old female patient, with no reported medical history, who experienced the non-serious, unexpected  event of Covid-19 on unknown date after the third dose of mRNA-1273 (Moderna COVID-19 Vaccine). The patient had mild symptoms and tested positive for Covid. The patient's age may have increased her risk of getting infected with Covid-19. The benefit-risk relationship of mRNA 1273 vaccine is not affected by this report.; Sender's Comments: This case concerns a 71-year-old female patient, with no reported medical history, who experienced the non-serious, unexpected  event of Covid-19 on unknown date after the third dose of mRNA-1273 (Moderna COVID-19 Vaccine). The patient had mild symptoms and tested positive for Covid. The patient's age may have increased her risk of getting infected with Covid-19. The benefit-risk relationship of mRNA 1273 vaccine is not affected by this report.
No additional adverse events reported; improperly stored dose of Proquad was administered to a patient; This spontaneous report as received from a medical assistant refers to a patient of unknown age and gender. There was no information about the patient's concurrent conditions, concomitant therapies or medical history provided.   On 22-OCT-2021, the patient was vaccinated with dose of improperly stored measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD), lot# U002534, expiration date was reported as 10-APR-2022, but upon internal validation process it was established as 24-JUL-2022, albumin status has been verified as recombinant human albumin (rHA), 0.5 mL (route of administration and anatomical location were not provided) for prophylaxis.   Administered dose of vaccine experienced the temperature excursions between 6 and 14 degrees Fahrenheit (F): (8.5 F) for 18 minutes, and 11.9 F for 1 hour. There were no previous excursions reported. No adverse events were reported.
pt recvd vax 17OCT95 & 28NOV95 pt devel 6 to 10 small lesions larger than pimples w/fluid-like sac on the trunk;
Information has been received from a physician via medical records concerning a 19-Week-old male with a family history of cancer and diabetes who on 03-DEC-2008 was vaccinated with a 0.5ml single dose of PEDIARIX (lot# AC71B1BAA) and a 0.5 single dose of PREVNAR (lot# G73459). On 29-JAN-2009 the patient was seen by a physician with a rash all over his body; a runny, stuffy,"green" nose; a congested cough; who was reportedly "crying a lot and not sleeping". At this appointment it was also noted that the patient was to be referred to the hospital for a "malshaped head". No outcome were reported. The next visit would be 09-FEB-2009 for the next shots. Additional information has been requested.
She experienced a rash on her face, chin, top of her chest and progressed to her shoulders as well.
bilateral pulmonary emboli with right heart strain diagnosed on 5/23/21.  Patient with no other known risk factors for PTE.  Symptom onset ~5/19/21
Heart palpitations: I experienced 3 tachycardia episodes between 5/28/21 and 7/2/21. Each heart episode was ~3 minutes long, and my heart rate was 160-200bpm during each episode. I began tracking my heart rhythm with a smart watch, and I also wore a Holter monitor for 48 hours to confirm diagnosis. I was diagnosed with supraventricular tachycardia by my primary care doctor on 6/4/21, and I was referred to a cardiologist who confirmed diagnosis on 7/22/21. I was prescribed propafenone to use PRN for heart palpitations. My echocardiogram showed normal results, no structural abnormalities of the heart. I am being considered for heart ablation surgery in the near future.
fast heart rate/it has been high every day; fast heart rate/it has been high every day; heart palpitations; This is a spontaneous report from a contactable consumer other non-health professional (Patient). A female patient unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot Number, Expiry date: Unknown), via an unspecified route of administration on 10Mar2021 as dose 1, single for COVID-19 immunisation. The patients medical history was high blood pressure since Jan2021 and got a machine to keep track of it and noticed in Feb2021 it was up 5-6 times. Fast heartbeat since Feb2021, prior to vaccine. The concomitant medications were not reported. On unspecified date in Mar2021, patient experienced fast heart rate/it has been high every day, heart palpitations. The patient stated that she was about to go for her second shot today at 9AM and she was leaving in half an hour, that she was reading about the side effects that could happen with the Pfizer vaccine, stated she has a fast heartbeat, up to 94 to 100s, stated that she was trying to deal with it with her doctor, she has had a fast heart beat since Feb2021, prior to vaccine, she had it a few times like 5-6 times in Feb, states she got the first shot on 10Mar2021 form 15Mar2021-23Mar2021 it was high about 4 times, and since 24Mar2021 it has been high every day 86, 106, 94, today it was 88. Stated one or two times it palpitated so much that it was hard to sleep, felt like it was going to beat out of her pajamas. Patient was wondering if it was connected to the vaccine. Patient wanted to know if she should get the vaccine and needs an answer within 20 minutes. Patient declined report, states she does not have time because she has to get to the appointment for her second dose and has to level low in 20 minutes. The report was not related to a study or programme. The outcome of the events was Unknown.   No follow-up attempts are possible. Information about lot/batch number cannot be obtained.
Arm was very sore after shot 1 from time of shot late afternoon of a Thursday until that Saturday afternoon. One week later, a red itchy hot rash appeared (have seen commonly referred to as Covid arm). It was very itchy for several days then was achy. The rash traveled down upper arm over the course of about a week before disappearing.   After shot 2, arm was immediately much more sore than shot 1 within 1 hour of receiving shot (could not lift arm up higher than shoulder height - this lasted for about 3 days). Was extremely fatigued the next day and had an extreme pounding headache as well as chills/hot flashes, a fever, aching joints (hips), and a very swollen injection site with red hot rash and elevated resting heart rate with the sensation of a thumping heart and tight chest. When moving, it felt like I was having an out of body experience/hallucinating. Was not about to get out of bed for the entire next day after the shot (Saturday). Had no appetite. Was able to get out of bed and most symptoms had abated by Sunday although still had limited appetite. On Monday of the following week (4/26), could barely eat or drink as about an hour after doing either, felt pressure on stomach along with bloating, tight chest/heartburn and nausea. This sensation lasted for about 5 days. Exercise, especially running, made it worse.
This case was reported by a nurse and described the occurrence of expired vaccine used in a 19-year-old male patient who received HAVRIX (batch number AHAVB597AA, expiry date 6th September 2014). On 12th November 2014, the patient received HAVRIX. On an unknown date, an unknown time after receiving HAVRIX, the patient experienced expired vaccine used. On an unknown date, the outcome of the expired vaccine used was unknown. Additional HAVRIX given to a 19 years old male.
Information has been received from a physician concerning his 11 year old son who was vaccinated with a dose of varicella virus vaccine live.  Subsequently, on 06/01/2004, the patient developed chickenpox breakthrough.  Unspecified medical attention was sought.  A product quality complaint was not involved.  The physician mentions a friend of his son also developed chickenpox post vaccination with varicella virus vaccine live.  The reporting physician also mentioned that he, himself, had negative titers post vaccination with varicella virus vaccine live.  Additional information has been requested.
p/vax pt rash; little red bumps all over; no fever; feeding well;
While being observed for 15 minutes post COVID 19 vaccination, pt complained of shakiness, swelling throat, flushing in chest and voice became hoarse. Upon assessment, pulse was 110, respirations 12, BP 176/98, SP02, 97% Client reported Hx of asthma and chemical allergies (non-anaphylactic).  Client administered albuterol to self, was given 12 ml oral diphenhydramine, and was actively monitored for 30 minutes.  Ending VS: P 91, R 12 BP 168/82, SPO2 on room air 97%.  Client reported feeling much improved; was taken home by spouse.
Felt lightheaded getting up in the observation area. Fell struck head lost consciousness times one minute. Complained of mild headache which cleared while being observed. Drank OJ and vomited it. No further nausea. Denies dizziness, neck pain, double vision, amnesia. Recovered fairly quickly while resting. Felt much better. Refused transport. Taken home by husband with instructions to monitor LOC. Follow up with family MD advised.
TC fr mom 130PM-LA swollen fr shoulder to elbow, hot to touch; prev rxn to DTP 10FEB88 to DTP-seen in hosp 15MAR89 DT given no rxn;